In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Biogen Idec acquires Fumapharm

Executive Summary

Biogen Idec has agreed to buy all the outstanding shares of Fumapharm AG (creates therapeutics from fumaric acid esters) for an undisclosed cash sum.
Deal Industry
  • Biotechnology
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Includes Earnout
    • Full Acquisition
    • Acquisition of Private Biotech
    • Payment Includes Cash

Related Companies

Advertisement
UsernamePublicRestriction

Register